Cargando…
Safety and efficacy of co-careldopa as an add-on therapy to occupational and physical therapy in patients after stroke (DARS): a randomised, double-blind, placebo-controlled trial
BACKGROUND: Dopamine is a key modulator of striatal function and learning and might improve motor recovery after stroke. Previous small trials of dopamine agonists after stroke provide equivocal evidence of effectiveness on improving motor recovery. We aimed to assess the safety and efficacy of co-c...
Autores principales: | Ford, Gary A, Bhakta, Bipin B, Cozens, Alastair, Hartley, Suzanne, Holloway, Ivana, Meads, David, Pearn, John, Ruddock, Sharon, Sackley, Catherine M, Saloniki, Eirini-Christina, Santorelli, Gillian, Walker, Marion F, Farrin, Amanda J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lancet Pub. Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6527868/ https://www.ncbi.nlm.nih.gov/pubmed/31122493 http://dx.doi.org/10.1016/S1474-4422(19)30147-4 |
Ejemplares similares
-
The DARS (Dopamine Augmented Rehabilitation in Stroke) trial: protocol for a randomised controlled trial of Co-careldopa treatment in addition to routine NHS occupational and physical therapy after stroke
por: Bhakta, Bipin B, et al.
Publicado: (2014) -
Maximising adherence to study protocol within pharmaco-rehabilitation clinical trials
por: Hartley, Suzanne, et al.
Publicado: (2011) -
Rapid set up of research centres in a trial in an evolving research governance world
por: Ruddock, Sharon, et al.
Publicado: (2013) -
Sample size in cluster randomised trials with unequal clusters
por: Holloway, Ivana, et al.
Publicado: (2011) -
Can follow-up reminders from postal questionnaires help determine the mechanism of missing data in trials?
por: Holloway, Ivana, et al.
Publicado: (2013)